These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 28229410
1. Therapeutic Application of Placental Mesenchymal Stem Cells Reprogrammed Neurospheres in Spinal Cord Injury of SCID. Sabapathy V, Herbert FJ, Kumar S. Methods Mol Biol; 2017; 1553():91-113. PubMed ID: 28229410 [Abstract] [Full Text] [Related]
2. Therapeutic Application of Human Wharton Jelly Mesenchymal Stem Cells in Skin Injury of SCID. Sabapathy V, Sundaram B, Kumar S. Methods Mol Biol; 2017; 1553():115-132. PubMed ID: 28229411 [Abstract] [Full Text] [Related]
3. One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells. Wei H, Tan G, Manasi, Qiu S, Kong G, Yong P, Koh C, Ooi TH, Lim SY, Wong P, Gan SU, Shim W. Stem Cell Res; 2012 Sep; 9(2):87-100. PubMed ID: 22683798 [Abstract] [Full Text] [Related]
4. Explants-isolated human placenta and umbilical cord cells share characteristics of both epithelial and mesenchymal stem cells. Anastasiu DM, Cean A, Bojin MF, Gluhovschi A, Panaitescu C, Păunescu V, Tănăsie G. Rom J Morphol Embryol; 2016 Sep; 57(2):383-90. PubMed ID: 27516009 [Abstract] [Full Text] [Related]
5. Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications. Moraghebi R, Kirkeby A, Chaves P, Rönn RE, Sitnicka E, Parmar M, Larsson M, Herbst A, Woods NB. Stem Cell Res Ther; 2017 Aug 25; 8(1):190. PubMed ID: 28841906 [Abstract] [Full Text] [Related]
6. Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications. Van Pham P, Truong NC, Le PT, Tran TD, Vu NB, Bui KH, Phan NK. Cell Tissue Bank; 2016 Jun 25; 17(2):289-302. PubMed ID: 26679929 [Abstract] [Full Text] [Related]
7. Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells as an Individual-Specific and Renewable Source of Adult Stem Cells. Sequiera GL, Saravanan S, Dhingra S. Methods Mol Biol; 2017 Jun 25; 1553():183-190. PubMed ID: 28229416 [Abstract] [Full Text] [Related]
8. New insights into the heterogeneity and functional diversity of human mesenchymal stem cells. Han ZC, Du WJ, Han ZB, Liang L. Biomed Mater Eng; 2017 Jun 25; 28(s1):S29-S45. PubMed ID: 28372276 [Abstract] [Full Text] [Related]
9. In Vitro Generation of Vascular Wall-Resident Multipotent Stem Cells of Mesenchymal Nature from Murine Induced Pluripotent Stem Cells. Steens J, Zuk M, Benchellal M, Bornemann L, Teichweyde N, Hess J, Unger K, Görgens A, Klump H, Klein D. Stem Cell Reports; 2017 Apr 11; 8(4):919-932. PubMed ID: 28366456 [Abstract] [Full Text] [Related]
10. Differentiation of hepatocytes from induced pluripotent stem cells derived from human hair follicle mesenchymal stem cells. Shi X, Lv S, He X, Liu X, Sun M, Li M, Chi G, Li Y. Cell Tissue Res; 2016 Oct 11; 366(1):89-99. PubMed ID: 27053247 [Abstract] [Full Text] [Related]
11. The Effect of Human Mesenchymal Stem Cells Derived from Wharton's Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application. Krupa P, Vackova I, Ruzicka J, Zaviskova K, Dubisova J, Koci Z, Turnovcova K, Urdzikova LM, Kubinova S, Rehak S, Jendelova P. Int J Mol Sci; 2018 May 17; 19(5):. PubMed ID: 29772841 [Abstract] [Full Text] [Related]
12. Production of Mesenchymal Stem Cells Through Stem Cell Reprogramming. Abdal Dayem A, Lee SB, Kim K, Lim KM, Jeon TI, Seok J, Cho AS. Int J Mol Sci; 2019 Apr 18; 20(8):. PubMed ID: 31003536 [Abstract] [Full Text] [Related]
13. Generation, Characterization, and Multilineage Potency of Mesenchymal-Like Progenitors Derived from Equine Induced Pluripotent Stem Cells. Lepage SI, Nagy K, Sung HK, Kandel RA, Nagy A, Koch TG. Stem Cells Dev; 2016 Jan 01; 25(1):80-9. PubMed ID: 26414480 [Abstract] [Full Text] [Related]
14. LNGFR+THY-1+ human pluripotent stem cell-derived neural crest-like cells have the potential to develop into mesenchymal stem cells. Ouchi T, Morikawa S, Shibata S, Fukuda K, Okuno H, Fujimura T, Kuroda T, Ohyama M, Akamatsu W, Nakagawa T, Okano H. Differentiation; 2016 Dec 01; 92(5):270-280. PubMed ID: 27178356 [Abstract] [Full Text] [Related]
15. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Heo JS, Choi Y, Kim HS, Kim HO. Int J Mol Med; 2016 Jan 01; 37(1):115-25. PubMed ID: 26719857 [Abstract] [Full Text] [Related]
16. Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy. Jiang G, Di Bernardo J, Maiden MM, Villa-Diaz LG, Mabrouk OS, Krebsbach PH, O'Shea KS, Kunisaki SM. Stem Cells Dev; 2014 Nov 01; 23(21):2613-25. PubMed ID: 25014361 [Abstract] [Full Text] [Related]
17. In vivo tracking of human placenta derived mesenchymal stem cells in nude mice via ¹⁴C-TdR labeling. Wu CG, Zhang JC, Xie CQ, Parolini O, Silini A, Huang YZ, Lian B, Zhang M, Huang YC, Deng L. BMC Biotechnol; 2015 Jun 13; 15():55. PubMed ID: 26070459 [Abstract] [Full Text] [Related]